Track SQZ Biotechnologies's net tangible assets ($1.9M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
SQZ Biotechnologies (SQZ) currently reports a net tangible assets of $1.9M as of September 2023. That compares with $69M in the prior-year period — down 97.3% year over year. Use the charts on this page to explore SQZ Biotechnologies's net tangible assets history and peer comparisons.
SQZ Biotechnologies's net tangible assets decreased from $69M to $1.9M — a 97.3% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
SQZ Biotechnologies reported $1.9M in net tangible assets as of September 2023. That compares with $69M in the prior-year period — down 97.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current net tangible assets of $1.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for SQZ Biotechnologies, and consider following SQZ for alerts when major investors trade the stock.
SQZ Biotechnologies is classified in the Healthcare sector. On net tangible assets, it currently shows $1.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SQZ with unrelated industries.